Clinical profile of patients with anterior nodular scleritis in India
Purpose: To report the clinical profile of a series of anterior nodular scleritis in Indian population. Methods: We conducted a retrospective review of medical records of 140 eyes of 123 consecutive patients with nodular scleritis who presented to a tertiary eye care institute between 2007 and 2018....
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Indian Journal of Ophthalmology |
Subjects: | |
Online Access: | http://www.ijo.in/article.asp?issn=0301-4738;year=2020;volume=68;issue=9;spage=1925;epage=1928;aulast=Patnaik |
_version_ | 1818519458628501504 |
---|---|
author | Gazal Patnaik Sridharan Sudharshan Amala E George Sudha K Ganesh Jyotirmay Biswas Parthopratim Dutta Majumder |
author_facet | Gazal Patnaik Sridharan Sudharshan Amala E George Sudha K Ganesh Jyotirmay Biswas Parthopratim Dutta Majumder |
author_sort | Gazal Patnaik |
collection | DOAJ |
description | Purpose: To report the clinical profile of a series of anterior nodular scleritis in Indian population. Methods: We conducted a retrospective review of medical records of 140 eyes of 123 consecutive patients with nodular scleritis who presented to a tertiary eye care institute between 2007 and 2018. Results: The mean age at presentation was 46.8 ± 13.1 years and 70.7% of the patients were female. Bilateral involvement was observed in 14% patients. The most common presenting symptom was redness (92.6%) and ocular pain (69.1%). Twenty-seven patients (22%) had some systemic association and rheumatoid arthritis (5%) was the most common autoimmune disease. Presumed ocular tuberculosis was diagnosed in 13% patients. Methotrexate was the most common immunosuppressive used in these patients and an additional immunosuppressive was required in 6.5% patients. Recurrence of inflammation was observed in 74.8% patients. Deterioration of vision noted in 2.8% eyes. Conclusion: Tuberculosis remains an important cause of nodular scleritis in India. Recurrence of scleritis is common in nodular scleritis and cases with non infectious nodular scleritis often require treatment with immune suppressives. |
first_indexed | 2024-12-11T01:24:29Z |
format | Article |
id | doaj.art-2593a5d9b84c4a45bc91bc713d3a7985 |
institution | Directory Open Access Journal |
issn | 0301-4738 1998-3689 |
language | English |
last_indexed | 2024-12-11T01:24:29Z |
publishDate | 2020-01-01 |
publisher | Wolters Kluwer Medknow Publications |
record_format | Article |
series | Indian Journal of Ophthalmology |
spelling | doaj.art-2593a5d9b84c4a45bc91bc713d3a79852022-12-22T01:25:36ZengWolters Kluwer Medknow PublicationsIndian Journal of Ophthalmology0301-47381998-36892020-01-016891925192810.4103/ijo.IJO_2154_19Clinical profile of patients with anterior nodular scleritis in IndiaGazal PatnaikSridharan SudharshanAmala E GeorgeSudha K GaneshJyotirmay BiswasParthopratim Dutta MajumderPurpose: To report the clinical profile of a series of anterior nodular scleritis in Indian population. Methods: We conducted a retrospective review of medical records of 140 eyes of 123 consecutive patients with nodular scleritis who presented to a tertiary eye care institute between 2007 and 2018. Results: The mean age at presentation was 46.8 ± 13.1 years and 70.7% of the patients were female. Bilateral involvement was observed in 14% patients. The most common presenting symptom was redness (92.6%) and ocular pain (69.1%). Twenty-seven patients (22%) had some systemic association and rheumatoid arthritis (5%) was the most common autoimmune disease. Presumed ocular tuberculosis was diagnosed in 13% patients. Methotrexate was the most common immunosuppressive used in these patients and an additional immunosuppressive was required in 6.5% patients. Recurrence of inflammation was observed in 74.8% patients. Deterioration of vision noted in 2.8% eyes. Conclusion: Tuberculosis remains an important cause of nodular scleritis in India. Recurrence of scleritis is common in nodular scleritis and cases with non infectious nodular scleritis often require treatment with immune suppressives.http://www.ijo.in/article.asp?issn=0301-4738;year=2020;volume=68;issue=9;spage=1925;epage=1928;aulast=Patnaikanterior nodular scleritiscyclophosphamidemethotrexatescleritistuberculosis |
spellingShingle | Gazal Patnaik Sridharan Sudharshan Amala E George Sudha K Ganesh Jyotirmay Biswas Parthopratim Dutta Majumder Clinical profile of patients with anterior nodular scleritis in India Indian Journal of Ophthalmology anterior nodular scleritis cyclophosphamide methotrexate scleritis tuberculosis |
title | Clinical profile of patients with anterior nodular scleritis in India |
title_full | Clinical profile of patients with anterior nodular scleritis in India |
title_fullStr | Clinical profile of patients with anterior nodular scleritis in India |
title_full_unstemmed | Clinical profile of patients with anterior nodular scleritis in India |
title_short | Clinical profile of patients with anterior nodular scleritis in India |
title_sort | clinical profile of patients with anterior nodular scleritis in india |
topic | anterior nodular scleritis cyclophosphamide methotrexate scleritis tuberculosis |
url | http://www.ijo.in/article.asp?issn=0301-4738;year=2020;volume=68;issue=9;spage=1925;epage=1928;aulast=Patnaik |
work_keys_str_mv | AT gazalpatnaik clinicalprofileofpatientswithanteriornodularscleritisinindia AT sridharansudharshan clinicalprofileofpatientswithanteriornodularscleritisinindia AT amalaegeorge clinicalprofileofpatientswithanteriornodularscleritisinindia AT sudhakganesh clinicalprofileofpatientswithanteriornodularscleritisinindia AT jyotirmaybiswas clinicalprofileofpatientswithanteriornodularscleritisinindia AT parthopratimduttamajumder clinicalprofileofpatientswithanteriornodularscleritisinindia |